Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Alphabet, Editas and Bio Palette-backed genomic medicine developer Beam will raise $180m in an upsized initial public offering three years after being spun out of Harvard University.

The Target-backed mattress and bedding brand is floating at the bottom of its range, at a valuation of less than half that of its last funding round.

Verana Health completed a $100m round led by existing investor GV that will help it expand its clinical database platform into new areas.

The investment enabled Koito Manufacturing to lead a series C round of undisclosed size for lidar system developer Cepton, which has now secured nearly $100m in total.

The private equity firm has hired GCV Powerlist mainstay Rob Salvagno, who had previously headed Cisco Investments, to co-lead its tech growth equity efforts.

Vineeta Agarwala has been confirmed as one of the general partners running the firm's $750m Bio Fund III following nearly five years at corporate venturing unit GV.

Existing investor Gradient Ventures invested in a series B round that almost doubled the clinical research software provider's overall funding to $45m.

The Mastercard-backed customer service bot developer took its total funding past $50m with $7m from Napier Park Financial Partners.

The biomedical commercialisation hub will invest $200,000 in four to six startups each year from University of Washington and other local centres of research.